​

Funding Round

Series B - Corsair Pharma

Series B - Corsair Pharma

Investment Firm

Overview

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

Announced Date

Sep 20, 2023

Closed on Date

Sep 20, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

New Rhein

New Rhein

New Rhein is a early_stage_venture and venture firm.

Participant Investors

4

Investor Name
Participant InvestorPlaisance Capital Management
Participant InvestorMidas Capital
Participant InvestorNew Rhein
Participant InvestorPrimavera Capital Group

Round Details and Background

Corsair Pharma raised $23000000 on 2023-09-20 in Series B

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 20, 2023
Series B - Corsair Pharma
5-23.0M

Recent Activity

News

Sep 21, 2023

FinSMEs - Corsair Pharma Raises $23M in Series B Financing

News

Sep 20, 2023

Yahoo! Finance - Corsair Pharma Announces $23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension